New York-based therapeutics biotech platform Terran Biosciences published a new World International Patent Organization (WIPO) application under the Patent Cooperation Treaty (PCT) to protect its novel, non-hallucinogenic psychoplastogens inspired in DMT and ibogaine with improved drug profiles.
See also: International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
While first-generation DMT has shown positive results in the treatment of depression and ibogaine for that of Substance Use Disorders …